Antibody and T-cell responses to SARS-CoV-2 vaccination in myeloproliferative neoplasm patients

Affiliations

• ¹ Department of Medical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA. jhow@bwh.harvard.edu.
• ² Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, 02115, USA. jhow@bwh.harvard.edu.
• ³ Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA. jhow@bwh.harvard.edu.
• ⁴ Immune Monitoring Laboratory, Cancer Center, Massachusetts General Hospital, Boston, MA, 02114, USA.
• ⁵ Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA, 02114, USA.
• ⁶ Department of Pathology, Harvard Medical School, Boston, MA, 02114, USA.
• ⁷ Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, 02115, USA.
• ⁸ Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.
• ⁹ Department of Medicine, Harvard Medical School, Boston, MA, 02114, USA.
• ¹⁰ Department of Medical Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.